Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

James Ford

Has grant

Professor

Stanford University

United States

Research Interests

Explore related searches

Professors in United States Professors in Cell Biology Cell Biology professors in United States

Recent Grants

Grant: Open

Improving Breast Cancer Genetic Risk Assessment and Treatment

Open Date: 2026-10-01

Close Date: 2028-09-30

Grant: Open

Stanford ACS DICR Internship Program

Open Date: 2025-01-01

Close Date: 2027-12-31

Grant: Close

Improving Breast Cancer Genetic Risk Assessment

Open Date: 2024-10-01

Close Date: 2025-09-30

Grant: Open

Institutional Research Grant

Open Date: 2024-01-01

Close Date: 2026-12-31

Grant: Close

Improving Breast Cancer Genetic Risk Assesment and Screening

Open Date: 2022-10-01

Close Date: 2023-09-30

Articles (19)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (10)

Shivaani Kummar

Oregon Health & Science University

UNITED STATES

View details

Raya Saab

Stanford University

UNITED STATES

View details

Eric T. Kool

Stanford University

UNITED STATES

View details

Oliver Dorigo

Stanford University School of Medicine

UNITED STATES

View details

Robert Gray

Dana-Farber Cancer Institute

UNITED STATES

View details

Aziz Khan

Assistant Professor

Mohamed Bin Zayed University of Artificial Intelligence

UNITED ARAB EMIRATES

View details

Christina Curtis

Professor of Medicine & Genetics

Stanford University

UNITED STATES

View details

Tina Andoh

University of Texas Southwestern Medical Center

UNITED STATES

View details

Melinda L Telli

Professor of Medicine

Stanford University School of Medicine

UNITED STATES

View details

prithvi mruthyunjaya

Professor

Stanford University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

James Ford

Research Interests

Explore related searches

Recent Grants

Articles (19)

Phase II Study of Adavosertib in Patients With Tumors Containing BRCA1 and BRCA2 Mutations: Results From the NCI-MATCH ECOG-ACRIN Cancer Research Group (EAY131) Subprotocol Z1I

Performance of PREMMplus in a racially and ethnically heterogenous population undergoing germline multigene panel testing.

A SMUG1 Inhibitor Modulates the Excision of Pyrimidine DNA Damage

Uterine serous carcinoma and germline genetic testing: patterns of referral, completion and pathogenic variant detection.

Evaluating a Mendelian Risk Prediction Model That Aggregates Across Genes and Cancers.

Exploring the Melanoma and Pancreatic Cancer Phenotype of a Potential CDKN2A Founder Variant, I49T (c.146T>C; p.Ile49Thr), in Individuals of Predominantly Mexican Ancestry.

Knowledge and Attitudes on Germline Pharmacogenomic Testing Among Clinical Oncologists.

A Four Amino Acid Intracellular Motif of VISTA Blocks Growth Receptor Signaling in Cancer Cells to Induce Tumor Suppression

Germline genetic testing in patients with uterine serous carcinoma at a tertiary academic center.

Polyclonal origins of human premalignant colorectal lesions.

Liposarcoma and Leiomyosarcoma as the First Manifestation of Familial Retinoblastoma: Implications for Genetic Testing and Carrier Surveillance

Functional Characterization of SDHB Variants Clarifies Hereditary Pheochromocytoma and Paraganglioma Risk and Genotype-Phenotype Relationships.

PARP inhibitor and PRMT5 inhibitor synergy is independent of BRCA1/2 and MTAP status in breast cancer cells.

A 20-feature radiomic signature of triple-negative breast cancer identifies patients at high risk of death.

Atriple-punch approach: methionine restriction enhances combination inhibitors in brain metastatic triple-negative breast cancer

MDM2 inhibition is associated with the emergence of TP53-altered clonal hematopoiesis.

Small-molecule activator of SMUG1 enhances repair of pyrimidine lesions in DNA.

VISTA-induced tumor suppression by a four amino acid intracellular motif.

Breast Cancer MRI Screening of Patients After Multiplex Gene Panel Testing.

Collaborators (10)

Shivaani Kummar

Raya Saab

Eric T. Kool

Oliver Dorigo

Robert Gray

Aziz Khan

Christina Curtis

Tina Andoh

Melinda L Telli

prithvi mruthyunjaya

Make your next move.